Pharos iBio (388870) Financial Statements

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025-11.5 billion KRW-10.8 billion KRW[source]
2024-12.6 billion KRW-10.6 billion KRW[source]
2023-10.1 billion KRW-8.9 billion KRW[source]
2022300 million KRW-10.6 billion KRW-17.1 billion KRW
202157 million KRW-8.4 billion KRW-31.5 billion KRW

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202529.5 billion KRW15.6 billion KRW13.9 billion KRW[source]
202419.2 billion KRW540 million KRW18.6 billion KRW[source]
202329.5 billion KRW1.1 billion KRW28.3 billion KRW[source]
2022
2021

This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.

Years without a source link are outside the DART financial API collection period.